Drugmaker Novartis AG has led to an end a 4 billion Swiss franc (US$3.55 billion; 2.4 billion EUR) share buyback program.
The program, which was announced in July, covers nearly 63.2 million shares that were purchased at an average price of 63.32 francs (US$56.16; 38.05 EUR), the company said.
Novartis said it will propose to shareholders at its next general meeting in February to cancel all shares from the latest buyback as well as nearly 22.2 million shares left over from a previous repurchase program completed in July.
The price of Novartis shares rose 0.8 percent to close at 64.35 francs (US$57.02; 38.63 EUR) on the Zurich exchange Friday.
The behavior of the Russian inspector satellite, which was launched in the autumn of 2017, puzzles military officials in the United States
When the bill was submitted to Congress on August 2, the reason for imposing the new sanctions on Russia was based on Russia's alleged interference in the US presidential election in 2016, but then something clicked